Massive Real-World study aims to unlock secrets of brain stimulation therapy

NCT ID NCT06917339

First seen Apr 12, 2026 · Last updated May 01, 2026 · Updated 3 times

Summary

This study will analyze data from over 150,000 people who received NeuroStar TMS (a non-invasive brain stimulation treatment) for depression, OCD, or anxiety. Researchers want to see how patient characteristics and treatment settings affect symptom improvement. The goal is to learn which factors lead to the best outcomes in real-world practice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEPRESSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Neuronetics

    RECRUITING

    Malvern, Pennsylvania, 19355, United States

    Contact

Conditions

Explore the condition pages connected to this study.